Bausch Health rises after $300M worth insider purchase

1 hour ago 1
Bausch Health US headquarters in Bridgewater, NJ, USA.

JHVEPhoto/iStock Editorial via Getty Images

Bausch Health (NYSE:BHC) shares added ~4% on Friday after John Paulson, a board member of the Canadian pharma giant, disclosed the purchase of more than $300M worth of company shares. Bausch + Lomb (BLCO), a Bausch

Recommended For You

More Trending News

Read Entire Article